290 related articles for article (PubMed ID: 19017052)
1. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.
Kashiwagi M; Aihara M; Takahashi Y; Yamazaki E; Yamane Y; Song Y; Muramatsu M; Ikezawa Z
J Dermatol; 2008 Oct; 35(10):683-5. PubMed ID: 19017052
[No Abstract] [Full Text] [Related]
2. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
Porteous DM; Berger TG
Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
[No Abstract] [Full Text] [Related]
3. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Goh TK; Pang SM; Thirumoorthy T; Goh SG
Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
[TBL] [Abstract][Full Text] [Related]
4. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
5. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
6. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
[TBL] [Abstract][Full Text] [Related]
7. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
8. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
10. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
11. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
Dainichi T; Uchi H; Moroi Y; Furue M
Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
[No Abstract] [Full Text] [Related]
13. [Blistering drug reactions].
Roujeau JC
Rev Prat; 2000 Jun; 50(12):1320-3. PubMed ID: 10972073
[TBL] [Abstract][Full Text] [Related]
14. Severe adverse cutaneous reactions to drugs.
Hughes-Davies L
N Engl J Med; 1995 Apr; 332(14):959; author reply 959-60. PubMed ID: 7794333
[No Abstract] [Full Text] [Related]
15. Severe drug-induced blistering disorders.
Roujeau JC
Rev Rhum Engl Ed; 1997 Jan; 64(1):5-9. PubMed ID: 9051853
[No Abstract] [Full Text] [Related]
16. Serious and life-threatening drug eruptions.
Manders SM
Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478
[TBL] [Abstract][Full Text] [Related]
17. HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population.
Niihara H; Kakamu T; Fujita Y; Kaneko S; Morita E
J Dermatol; 2012 Jul; 39(7):594-601. PubMed ID: 22211527
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition of life-threatening antiepileptic-induced skin reactions.
Chung WH; Hung SI; Chen YT
Expert Opin Drug Saf; 2010 Jan; 9(1):15-21. PubMed ID: 20001755
[TBL] [Abstract][Full Text] [Related]
19. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
[TBL] [Abstract][Full Text] [Related]
20. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
